Durga S. Borkar

Aug 29, 2024 | retinatoday.com | Gemmy Cheung |Durga S. Borkar

September 2024 | Features The latest DRCR Retina Network data suggest that patient selection is key to choosing the best treatment approach. Protocol AB compared 2 mg aflibercept (Eylea, Regeneron) with vitrectomy with panretinal photocoagulation for diabetic vitreous hemorrhage. In Protocol AB, two-thirds of patients in the aflibercept treatment arm did equally well with medical management alone and were spared surgical intervention.

Jul 19, 2024 | healio.com | Durga S. Borkar |Anthony DeFino |Christine Klimanskis

Read more You've successfully added Retina/Vitreous in Ophthalmology to your alerts. You will receive an email when new content is published. Click Here to Manage Email Alerts We were unable to process your request. Please try again later. If you continue to have this issue please contact [email protected].

Sep 10, 2023 | healio.com | Durga S. Borkar |Anthony DeFino |Christine Klimanskis

Source/Disclosures Source: Borkar D. Early treatment patterns and outcomes in patients with diabetic macular edema treated with faricimab: FARETINA-DME study. Presented at: American Society of Retina Specialists annual meeting; July 28-Aug. 1, 2023; Seattle. Disclosures: Borkar reports consulting for Genentech and Verana Health. You've successfully added Ophthalmology: Retina/Vitreous to your alerts. You will receive an email when new content is published.